China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu ...

The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at ...

As more drugs go subcutaneous, CEO of Phillips Medisize, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.

The Philippine Chamber of Pharmaceutical Industry expressed strong support for the Food and Drug Administration’s efforts to institutionalize a "green ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

European leaders prepared to counteract US economic pressure with the Anti-Coercion Instrument, highlighting the potential ...

Nestled in the Pegasus Park complex in Dallas, a globally recognized center for life science innovation, business and social ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...